Search
Search Results
##search.searchResults.foundPlural##
-
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4480PDF: 1916HTML: 17733 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5261PDF: 2556HTML: 30190Antinori Tables 1,2,3: 346 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2175PDF: 1165HTML: 2585Study of serum haptoglobin level in thalassemia: 342Figures: 175 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4242PDF: 1172HTML: 2151Figure 1: 163 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2640PDF: 1074HTML: 113 -
Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome
3522PDF: 981HTML: 425Table 1.: 225 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2052PDF: 636HTML: 261 -
BONE MARROW ABONRMALITIES IN HIV INFECTION
1863PDF: 1132HTML: 1757 -
LATERAL SINUS THROMBOSIS IN OTOLOGY: A REVIEW
1572PDF: 931HTML: 4094Letter: 171 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1603PDF: 985HTML: 354 -
PREVENTION OF POST-TRANSFUSION HEPATITIS BY SCREENING OF ANTIBODY TO HEPATITIS B CORE ANTIGEN IN HEALTHY BLOOD DONORS
1148PDF: 679HTML: 1244Title page: 198 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1704PDF: 624HTML: 1513Figure 1: MRI demonstrating Aspergillus synovitis: 183Figure 2:MRI demonstrating Aspergillus synovitis: 187 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3220PDF: 1004HTML: 2023 -
Sickle cell disease and Bartonella spp. infection
1155PDF: 863HTML: 453 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4235PDF: 1514HTML: 445 -
WHAT ARE FUNGAL INFECTIONS?
4163PDF: 2369HTML: 27593de Pauw: 235 -
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1186PDF: 814HTML: 73 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3538PDF: 2402HTML: 1458 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3961PDF: 1297HTML: 2258 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2193PDF: 941HTML: 5059Cover Letter: 168Figure 2: 160Figure 1: 172Figure 3: 194Figure 4: 166Figure Legend: 184Table 1: 186Table 2: 179Table 3: 178 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1771PDF: 698HTML: 335 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4714PDF: 1549HTML: 2251Untitled: 206Untitled: 222Untitled: 230Untitled: 212Untitled: 214 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3540PDF: 1477HTML: 4385CoverLetter: 183Figure1: 194 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
964PDF: 357HTML: 190 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1450PDF: 1051HTML: 215 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3668PDF: 1281HTML: 727Figure 2: 450Figure 1: 3115 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1767PDF: 1009HTML: 2034cover: 180Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 173Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 466title page: 186 -
PROPHYLAXIS OF MALARIA
3001PDF: 1018HTML: 17792Figures SChwartz: 163







